SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emma Muñoz-Sáez, Estefanía de Munck García, Rosa Mª Arahuetes Portero, Ana Martínez, Mª Teresa Solas Alados, Begoña Gómez Miguel, Analysis of β-N-methylamino-l-alanine (L-BMAA) neurotoxicity in rat cerebellum, NeuroToxicology, 2015, 48, 192

    CrossRef

  2. 2
    Lorraine V. Kalia, Suneil K. Kalia, Anthony E. Lang, Disease-modifying strategies for Parkinson's disease, Movement Disorders, 2015, 30, 10
  3. 3
    Arash Nazeri, Tina Roostaei, Shokufeh Sadaghiani, M. Mallar Chakravarty, Shirley Eberly, Anthony E. Lang, Aristotle N. Voineskos, Genome-wide variant by serum urate interaction in Parkinson's disease, Annals of Neurology, 2015, 78, 3
  4. 4
    Xiao-ling Qin, Qing-shan Zhang, Li Sun, Meng-wei Hao, Zhao-ting Hu, Lower Serum Bilirubin and Uric Acid Concentrations in Patients with Parkinson’s Disease in China, Cell Biochemistry and Biophysics, 2015, 72, 1, 49

    CrossRef

  5. 5
    Rachit Bakshi, Hong Zhang, Robert Logan, Ila Joshi, Yuehang Xu, Xiqun Chen, Michael A. Schwarzschild, Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release, Neurobiology of Disease, 2015,

    CrossRef

  6. 6
    Juan Segura-Aguilar, Richard M. Kostrzewa, Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update, Neurotoxicity Research, 2015, 27, 3, 328

    CrossRef

  7. 7
    Jae-Sun Choi, Woom-Yee Bae, Chan Park, Joo-Won Jeong, Zingerone activates VMAT2 during MPP+-induced Cell Death, Phytotherapy Research, 2015, 29, 8
  8. 8
    Danny Bega, Paulina Gonzalez-Latapi, Cindy Zadikoff, Tanya Simuni, A Review of the Clinical Evidence for Complementary and Alternative Therapies in Parkinson’s Disease, Current Treatment Options in Neurology, 2014, 16, 10

    CrossRef

  9. 9
    Julijana Ivanisevic, Adrian A. Epstein, Michael E. Kurczy, Paul H. Benton, Winnie Uritboonthai, Howard S. Fox, Michael D. Boska, Howard E. Gendelman, Gary Siuzdak, Brain Region Mapping Using Global Metabolomics, Chemistry & Biology, 2014, 21, 11, 1575

    CrossRef

  10. 10
    Danny Bega, Cindy Zadikoff, Complementary & Alternative Management of Parkinson’s Disease: An Evidence-Based Review of Eastern Influenced Practices, Journal of Movement Disorders, 2014, 7, 2, 57

    CrossRef

  11. 11
    Maria Antonietta De Luca, Omar Cauli, Micaela Morelli, Nicola Simola, Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?, Journal of Neurochemistry, 2014, 131, 3
  12. 12
    S. Cipriani, R. Bakshi, M.A. Schwarzschild, Protection by inosine in a cellular model of Parkinson’s disease, Neuroscience, 2014, 274, 242

    CrossRef

  13. 13
    Yuan Xu, Hua-Ping Du, Jiaojiao Li, Ran Xu, Ya-Li Wang, Shou-Jiang You, Huihui Liu, Fen Wang, Yong-Jun Cao, Chun-Feng Liu, Li-Fang Hu, Statins upregulate cystathionine γ-lyase transcription and H2S generation via activating Akt signaling in macrophage, Pharmacological Research, 2014, 87, 18

    CrossRef

  14. 14
    X. Chen, T. C. Burdett, C. A. Desjardins, R. Logan, S. Cipriani, Y. Xu, M. A. Schwarzschild, Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration, Proceedings of the National Academy of Sciences, 2013, 110, 1, 300

    CrossRef

  15. 15
    Naoko H Tomioka, Makiko Nakamura, Masaru Doshi, Yoshiharu Deguchi, Kimiyoshi Ichida, Takayuki Morisaki, Makoto Hosoyamada, Ependymal cells of the mouse brain express urate transporter 1 (URAT1), Fluids and Barriers of the CNS, 2013, 10, 1, 31

    CrossRef

  16. 16
    Isabel González-Aramburu, Pascual Sánchez-Juan, Silvia Jesús, Ana Gorostidi, Eduardo Fernández-Juan, Fátima Carrillo, María Sierra, Pilar Gómez-Garre, María T. Cáceres-Redondo, José Berciano, Javier Ruiz-Martínez, Onofre Combarros, Pablo Mir, Jon Infante, Genetic variability related to serum uric acid concentration and risk of Parkinson's disease, Movement Disorders, 2013, 28, 12
  17. 17
    A. Garcia-Garcia, A. Anandhan, M. Burns, H. Chen, Y. Zhou, R. Franco, Impairment of Atg5-Dependent Autophagic Flux Promotes Paraquat- and MPP+-Induced Apoptosis But Not Rotenone or 6-Hydroxydopamine Toxicity, Toxicological Sciences, 2013, 136, 1, 166

    CrossRef

  18. 18
    M.P. Cunha, M.D. Martín-de-Saavedra, A. Romero, E. Parada, J. Egea, L. del Barrio, A.L.S. Rodrigues, M.G. López, Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways, Neuroscience, 2013, 238, 185

    CrossRef